Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

被引：0
|
作者：
Hu, Bei [1 ]
Korsos, Victoria [2 ]
Palomba, M. Lia [2 ,3 ]
机构：
[1] Wake Forest Sch Med, Atrium Hlth Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC 28202 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
chimeric antigen receptor T cell therapy (CAR T cell therapy); diffuse large B cell lymphoma (DLBCL); high grade B cell lymphoma; mantle cell lymphoma (MCL); relapsed and refractory lymphoma; CENTRAL-NERVOUS-SYSTEM; AXICABTAGENE CILOLEUCEL; COST-EFFECTIVENESS; BREXUCABTAGENE AUTOLEUCEL; PREDICTIVE FACTORS; OUTCOMES; MULTICENTER; INFLAMMATION; PERSISTENCE; IBRUTINIB;
D O I：
10.3389/fonc.2024.1394057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell lymphoma and mantle cell lymphoma, highlighting their efficacy and toxicity as well as discussing future directions.
引用
收藏
页数：13
相关论文
共 50 条
  • [41] Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy
    Voltin, Conrad-Amadeus
    Godel, Philipp
    Beckmann, Laura
    Heger, Jan-Michel
    Kobe, Carsten
    Kutsch, Nadine
    Borchmann, Peter
    Dietlein, Markus
    Herrmann, Ken
    Stelljes, Matthias
    Rahbar, Kambiz
    Lenz, Georg
    Reinhardt, H. Christian
    Teichert, Marcel
    Noppeney, Richard
    Albring, Jorn C.
    Seifert, Robert
    von Tresckow, Bastian
    Flossdorf, Sarah
    Hanoun, Christine
    HEMASPHERE, 2023, 7 (01): : E817
  • [42] Characterization of Infections After Chimeric Antigen Receptor T-Cell Therapy in Patients With Large B-Cell Lymphoma
    Pernas, Berta
    Iacoboni, Gloria
    Los-Arcos, Ibai
    Catala, Eva
    Carpio, Cecilia
    Barba, Pere
    Ruiz-Camps, Isabel
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 196 - 196
  • [43] Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Current Landscape in 2021
    Gauthier, Jordan
    Turtle, Cameron J.
    CANCER JOURNAL, 2021, 27 (02): : 98 - 106
  • [44] Histopathologic evidence of chimeric antigen receptor T-cell therapy in lesions of B-cell lymphoblastic leukemia cutis
    Nihal, Aman
    Comstock, Jeanette R.
    Bennett, Daniel D.
    Mattison, Ryan J.
    Nadiminti, Kalyan Vara Ganesh
    Keenan, Thomas
    JOURNAL OF CUTANEOUS PATHOLOGY, 2024, 51 (08) : 562 - 564
  • [45] Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes
    Bourlon, Christianne
    Roddie, Claire
    Menne, Tobias
    Norman, Jane
    O'Reilly, Maeve
    Gibb, Adam
    Besley, Caroline
    Chaganti, Sridhar
    Arias, Carlos Gonzalez
    Jones, Ceri
    Dikair, Abdalla
    Allen, Sharon
    Seymour, Frances
    Osborne, Wendy
    Mathew, Amrith
    Townsend, William
    Patten, Piers E. M.
    Thoulouli, Eleni
    Abdulgawad, Ahmed
    Lugthart, Sanne
    Sanderson, Robin
    Kirkwood, Amy A.
    Kuhnl, Andrea
    HAEMATOLOGICA, 2024, 109 (08) : 2716 - 2720
  • [46] Pyoderma Gangrenosum Secondary to Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
    Mager, Layna
    Mcfeeters, Jacob
    Plaza, Jose A.
    Dulmage, Brittany
    Kaffenberger, Benjamin H.
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2025, 37 (01): : 5 - 7
  • [47] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Strati, Paolo
    Ahmed, Sairah
    Furqan, Fateeha
    Fayad, Luis E.
    Lee, Hun J.
    Iyer, Swaminathan P.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Parmar, Simrit
    Rodriguez, Maria A.
    Samaniego, Felipe
    Steiner, Raphael E.
    Wang, Michael
    Pinnix, Chelsea C.
    Horowitz, Sandra B.
    Feng, Lei
    Sun, Ryan
    Claussen, Catherine M.
    Hawkins, Misha C.
    Johnson, Nicole A.
    Singh, Prachee
    Mistry, Haleigh
    Johncy, Swapna
    Adkins, Sherry
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Green, Michael R.
    Flowers, Christopher R.
    Westin, Jason
    Neelapu, Sattva S.
    BLOOD, 2021, 137 (23) : 3272 - 3276
  • [48] Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia
    Diamond, Yonatan
    Gilsenan, Maddie
    Wang, Stacie Shiqi
    Hanna, Diane
    Conyers, Rachel
    Cole, Theresa
    Hughes, David
    Fleming, Jacqueline
    Meyran, Deborah
    Toro, Claudia
    Malalasekera, Vajiranee
    Khaw, Seong Lin
    Haeusler, Gabrielle M.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [49] Frequency of secondary T-cell lymphoma in chimeric antigen receptor T-cell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen T-cell therapy
    Brieghel, Christian
    Petersen, Soren L.
    Brown, Peter de N.
    Niemann, Carsten U.
    HAEMATOLOGICA, 2025, 110 (03) : 768 - 771
  • [50] Chimeric Antigen Receptor Therapy for B-cell Malignancies
    Porter, David L.
    Kalos, Michael
    Zheng, Zhaohui
    Levine, Bruce
    June, Carl
    JOURNAL OF CANCER, 2011, 2 : 331 - 332
12345